Valuation: AbbVie Inc.

Market Cap 44TCr 14,60600Cr 38TCr 36TCr 33TCr 61TCr 42,29600Cr 62TCr 4,20000Cr 1,64600Cr 21,19000Cr 1,66100Cr 1,62500Cr 70,48800Cr P/E 2026 *
32x
P/E 2027 * 23.6x
Enterprise Value 50TCr 16,60400Cr 43TCr 41TCr 37TCr 70TCr 48,07900Cr 71TCr 4,77400Cr 1,87100Cr 24,08800Cr 1,88800Cr 1,84700Cr 80,12700Cr EV / Sales 2026 *
7.44x
EV / Sales 2027 * 6.72x
Free-Float
95.71%
Yield 2026 *
2.74%
Yield 2027 * 2.88%
1 day-1.80%
1 week+0.61%
Current month-4.65%
1 month-4.65%
3 months+19.71%
6 months+13.89%
Current year+12.33%
1 week 8.2
Extreme 8.2
8.45
1 month 8
Extreme 8
8.85
Current year 6.25
Extreme 6.25
8.85
1 year 6.25
Extreme 6.25
8.85
3 years 6.25
Extreme 6.25
8.85
5 years 6.25
Extreme 6.25
8.85
10 years 6.25
Extreme 6.25
8.85
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%+0.61% - - 44TCr
+0.25%-3.96%+68.73%+120.06% 1,05500Cr
+0.78%+0.21%+48.53%+50.78% 63TCr
+0.35%+0.95%+21.11%+66.86% 44TCr
+1.00%-2.52%+40.47%+40.99% 35TCr
+0.51%-1.46%+23.75%+38.74% 29TCr
+0.41%-2.06%-1.18%+8.84% 24TCr
+1.00%+0.52%+41.46%+58.95% 23TCr
-0.15%-4.98%-16.00%-53.34% 20TCr
+0.40%+4.40%+17.36%+81.59% 17TCr
Average +0.27%-1.44%+27.14%+45.94% 40.14TCr
Weighted average by Cap. +0.24%-1.87%+39.44%+64.44%

Financials

2026 *2027 *
Net sales 6.76TCr 2,23200Cr 5.83TCr 5.47TCr 4.99TCr 9.37TCr 6,46200Cr 9.5TCr 64TCr 25TCr 3,23700Cr 25TCr 25TCr 10,76900Cr 7.35TCr 2,42800Cr 6.35TCr 5.95TCr 5.42TCr 10TCr 7,02900Cr 10TCr 70TCr 27TCr 3,52200Cr 28TCr 27TCr 11,71500Cr
Net income 1.39TCr 46TCr 1.2TCr 1.12TCr 1.02TCr 1.92TCr 1,32500Cr 1.95TCr 13TCr 5.16TCr 66TCr 5.2TCr 5.09TCr 2,20900Cr 1.89TCr 62TCr 1.63TCr 1.53TCr 1.4TCr 2.62TCr 1,80800Cr 2.66TCr 18TCr 7.04TCr 91TCr 7.1TCr 6.95TCr 3,01400Cr
Net Debt 6.05TCr 1,99700Cr 5.22TCr 4.9TCr 4.46TCr 8.39TCr 5,78400Cr 8.51TCr 57TCr 23TCr 2,89800Cr 23TCr 22TCr 9,63900Cr 5.17TCr 1,70600Cr 4.46TCr 4.18TCr 3.81TCr 7.17TCr 4,93900Cr 7.27TCr 49TCr 19TCr 2,47500Cr 19TCr 19TCr 8,23200Cr
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
17/26/17 THB 8.200 -1.80% 9,495
14/26/14 THB 8.350 +1.21% 2,20,433
13/26/13 THB 8.250 +0.61% 2,11,605
11/26/11 THB 8.200 +0.61% 32,594
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
250.33USD
Average target price
276.41USD
Spread / Average Target
+10.42%

Quarterly revenue - Rate of surprise